Bharat Immunologicals & Biologicals Corporation: Submission Of Unaudited Quarterly Financial Results Alongwith Limited Review Report For The Quarter Ended June 2023 As Compliance Of LODR 2015

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

For grievances: [email protected]